US BANCORP \DE\ - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V501. A total of 25 filers reported holding BIOCEPT INC in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2023$198
-35.9%
5830.0%0.00%
Q4 2022$3095830.0%0.00%
Q3 2022$05830.0%0.00%
Q2 2022$0
-100.0%
5830.0%0.00%
Q1 2022$1,000
-50.0%
5830.0%0.00%
Q4 2021$2,0000.0%5830.0%0.00%
Q3 2021$2,0000.0%5830.0%0.00%
Q2 2021$2,000
-33.3%
5830.0%0.00%
Q1 2021$3,000
+50.0%
5830.0%0.00%
Q4 2020$2,000
-33.3%
583
-13.6%
0.00%
Q3 2020$3,0006750.00%
Other shareholders
BIOCEPT INC shareholders Q2 2021
NameSharesValueWeighting ↓
OCCUDO QUANTITATIVE STRATEGIES LP 31,132$138,0000.04%
SABBY MANAGEMENT, LLC 31,578$140,0000.03%
DRIEHAUS CAPITAL MANAGEMENT LLC 111,111$493,0000.01%
Virtu Financial LLC 14,647$65,0000.01%
HUSSMAN STRATEGIC ADVISORS, INC. 3,500$16,0000.00%
Larson Financial Group LLC 1,000$4,0000.00%
VANGUARD GROUP INC 667,242$2,963,0000.00%
Advisory Services Network, LLC 1$00.00%
Man Group plc 16,600$74,0000.00%
OSAIC HOLDINGS, INC. 7,000$31,0000.00%
View complete list of BIOCEPT INC shareholders